Aptevo Therapeutics Inc (APVO)
0.1691
0.00 (0.00%)
USD |
NASDAQ |
Oct 04, 16:00
0.166
0.00 (0.00%)
After-Hours: 20:00
Aptevo Therapeutics Shareholders Equity (Annual): 12.22M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.22M |
| December 31, 2022 | 17.97M |
| December 31, 2021 | 1.216M |
| December 31, 2020 | 16.59M |
| December 31, 2019 | 11.84M |
| Date | Value |
|---|---|
| December 31, 2018 | 30.41M |
| December 31, 2017 | 82.04M |
| December 31, 2016 | 50.57M |
| December 31, 2015 | 88.62M |
| December 31, 2014 | 94.61M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
1.216M
Minimum
2021
17.97M
Maximum
2022
11.97M
Average
12.22M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Cassava Sciences Inc | 137.47M |
| Ocular Therapeutix Inc | 91.13M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |